nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—SLC22A4—larynx—thyroid cancer	0.0399	0.323	CbGeAlD
Ipratropium bromide—CYP3A4—Vandetanib—thyroid cancer	0.0341	0.286	CbGbCtD
Ipratropium bromide—CYP2D6—Sorafenib—thyroid cancer	0.0323	0.271	CbGbCtD
Ipratropium bromide—CYP3A4—Sorafenib—thyroid cancer	0.0205	0.173	CbGbCtD
Ipratropium bromide—CYP2D6—Doxorubicin—thyroid cancer	0.0196	0.165	CbGbCtD
Ipratropium bromide—CYP3A4—Doxorubicin—thyroid cancer	0.0125	0.105	CbGbCtD
Ipratropium bromide—SLC22A4—neck—thyroid cancer	0.0106	0.0857	CbGeAlD
Ipratropium bromide—CHRM1—saliva-secreting gland—thyroid cancer	0.00728	0.059	CbGeAlD
Ipratropium bromide—CHRM3—saliva-secreting gland—thyroid cancer	0.00651	0.0528	CbGeAlD
Ipratropium bromide—SLC22A4—trachea—thyroid cancer	0.00636	0.0516	CbGeAlD
Ipratropium bromide—CHRM5—head—thyroid cancer	0.00631	0.0511	CbGeAlD
Ipratropium bromide—Sinusitis—Vandetanib—thyroid cancer	0.00565	0.00745	CcSEcCtD
Ipratropium bromide—CHRM1—trachea—thyroid cancer	0.00561	0.0455	CbGeAlD
Ipratropium bromide—SLC22A5—saliva-secreting gland—thyroid cancer	0.00546	0.0442	CbGeAlD
Ipratropium bromide—Haemoglobin—Vandetanib—thyroid cancer	0.00543	0.00717	CcSEcCtD
Ipratropium bromide—Haemorrhage—Vandetanib—thyroid cancer	0.0054	0.00713	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Vandetanib—thyroid cancer	0.00534	0.00704	CcSEcCtD
Ipratropium bromide—Urethral disorder—Vandetanib—thyroid cancer	0.0053	0.00699	CcSEcCtD
Ipratropium bromide—Visual impairment—Vandetanib—thyroid cancer	0.00521	0.00687	CcSEcCtD
Ipratropium bromide—Eye disorder—Vandetanib—thyroid cancer	0.00505	0.00666	CcSEcCtD
Ipratropium bromide—SLC22A4—thyroid gland—thyroid cancer	0.00503	0.0408	CbGeAlD
Ipratropium bromide—Cardiac disorder—Vandetanib—thyroid cancer	0.00501	0.00662	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Vandetanib—thyroid cancer	0.00487	0.00643	CcSEcCtD
Ipratropium bromide—Local reaction—Epirubicin—thyroid cancer	0.00484	0.00639	CcSEcCtD
Ipratropium bromide—Dysgeusia—Vandetanib—thyroid cancer	0.00461	0.00608	CcSEcCtD
Ipratropium bromide—Dysphagia—Sorafenib—thyroid cancer	0.00455	0.00601	CcSEcCtD
Ipratropium bromide—Local reaction—Doxorubicin—thyroid cancer	0.00448	0.00592	CcSEcCtD
Ipratropium bromide—Vision blurred—Vandetanib—thyroid cancer	0.00443	0.00585	CcSEcCtD
Ipratropium bromide—Tremor—Vandetanib—thyroid cancer	0.00441	0.00582	CcSEcCtD
Ipratropium bromide—Abdominal discomfort—Sorafenib—thyroid cancer	0.00437	0.00576	CcSEcCtD
Ipratropium bromide—CHRM2—head—thyroid cancer	0.00433	0.0351	CbGeAlD
Ipratropium bromide—SLC22A5—trachea—thyroid cancer	0.00421	0.0341	CbGeAlD
Ipratropium bromide—Cough—Vandetanib—thyroid cancer	0.0041	0.00542	CcSEcCtD
Ipratropium bromide—Hypertension—Vandetanib—thyroid cancer	0.00406	0.00536	CcSEcCtD
Ipratropium bromide—Chest pain—Vandetanib—thyroid cancer	0.004	0.00529	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00398	0.00525	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00398	0.00525	CcSEcCtD
Ipratropium bromide—CHRM3—thyroid gland—thyroid cancer	0.00397	0.0322	CbGeAlD
Ipratropium bromide—Stomatitis—Sorafenib—thyroid cancer	0.00396	0.00522	CcSEcCtD
Ipratropium bromide—CHRM1—head—thyroid cancer	0.00394	0.0319	CbGeAlD
Ipratropium bromide—Dry mouth—Vandetanib—thyroid cancer	0.00392	0.00517	CcSEcCtD
Ipratropium bromide—Oedema—Vandetanib—thyroid cancer	0.00384	0.00507	CcSEcCtD
Ipratropium bromide—Epistaxis—Sorafenib—thyroid cancer	0.00383	0.00505	CcSEcCtD
Ipratropium bromide—Infection—Vandetanib—thyroid cancer	0.00381	0.00503	CcSEcCtD
Ipratropium bromide—Lung disorder—Epirubicin—thyroid cancer	0.00379	0.005	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Vandetanib—thyroid cancer	0.00376	0.00497	CcSEcCtD
Ipratropium bromide—Skin disorder—Vandetanib—thyroid cancer	0.00373	0.00492	CcSEcCtD
Ipratropium bromide—Haemoglobin—Sorafenib—thyroid cancer	0.00366	0.00484	CcSEcCtD
Ipratropium bromide—Haemorrhage—Sorafenib—thyroid cancer	0.00364	0.00481	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Sorafenib—thyroid cancer	0.0036	0.00475	CcSEcCtD
Ipratropium bromide—Urethral disorder—Sorafenib—thyroid cancer	0.00357	0.00472	CcSEcCtD
Ipratropium bromide—CHRM3—head—thyroid cancer	0.00353	0.0286	CbGeAlD
Ipratropium bromide—Lung disorder—Doxorubicin—thyroid cancer	0.00351	0.00463	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.0035	0.00462	CcSEcCtD
Ipratropium bromide—Insomnia—Vandetanib—thyroid cancer	0.00347	0.00458	CcSEcCtD
Ipratropium bromide—Paraesthesia—Vandetanib—thyroid cancer	0.00345	0.00455	CcSEcCtD
Ipratropium bromide—Dyspnoea—Vandetanib—thyroid cancer	0.00342	0.00452	CcSEcCtD
Ipratropium bromide—Tinnitus—Sorafenib—thyroid cancer	0.0034	0.00449	CcSEcCtD
Ipratropium bromide—Flushing—Sorafenib—thyroid cancer	0.00338	0.00446	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Sorafenib—thyroid cancer	0.00338	0.00446	CcSEcCtD
Ipratropium bromide—Dyspepsia—Vandetanib—thyroid cancer	0.00338	0.00446	CcSEcCtD
Ipratropium bromide—SLC22A5—thyroid gland—thyroid cancer	0.00333	0.027	CbGeAlD
Ipratropium bromide—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00331	0.00437	CcSEcCtD
Ipratropium bromide—Fatigue—Vandetanib—thyroid cancer	0.00331	0.00437	CcSEcCtD
Ipratropium bromide—Immune system disorder—Sorafenib—thyroid cancer	0.00329	0.00435	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Sorafenib—thyroid cancer	0.00328	0.00434	CcSEcCtD
Ipratropium bromide—Constipation—Vandetanib—thyroid cancer	0.00328	0.00433	CcSEcCtD
Ipratropium bromide—Pain—Vandetanib—thyroid cancer	0.00328	0.00433	CcSEcCtD
Ipratropium bromide—Dysphonia—Epirubicin—thyroid cancer	0.00326	0.0043	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00314	0.00414	CcSEcCtD
Ipratropium bromide—SLC22A4—lymph node—thyroid cancer	0.00313	0.0253	CbGeAlD
Ipratropium bromide—Dysgeusia—Sorafenib—thyroid cancer	0.00311	0.0041	CcSEcCtD
Ipratropium bromide—Cardiovascular disorder—Epirubicin—thyroid cancer	0.00305	0.00403	CcSEcCtD
Ipratropium bromide—Abdominal pain—Vandetanib—thyroid cancer	0.00303	0.00401	CcSEcCtD
Ipratropium bromide—Dysphonia—Doxorubicin—thyroid cancer	0.00302	0.00398	CcSEcCtD
Ipratropium bromide—Angioedema—Sorafenib—thyroid cancer	0.0029	0.00383	CcSEcCtD
Ipratropium bromide—Ulcer—Epirubicin—thyroid cancer	0.00284	0.00374	CcSEcCtD
Ipratropium bromide—Cardiovascular disorder—Doxorubicin—thyroid cancer	0.00282	0.00373	CcSEcCtD
Ipratropium bromide—Cough—Sorafenib—thyroid cancer	0.00277	0.00365	CcSEcCtD
Ipratropium bromide—Inflammation—Epirubicin—thyroid cancer	0.00277	0.00365	CcSEcCtD
Ipratropium bromide—Asthenia—Vandetanib—thyroid cancer	0.00275	0.00364	CcSEcCtD
Ipratropium bromide—Hypertension—Sorafenib—thyroid cancer	0.00274	0.00362	CcSEcCtD
Ipratropium bromide—Pruritus—Vandetanib—thyroid cancer	0.00272	0.00358	CcSEcCtD
Ipratropium bromide—Myalgia—Sorafenib—thyroid cancer	0.0027	0.00357	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00268	0.00354	CcSEcCtD
Ipratropium bromide—Dry mouth—Sorafenib—thyroid cancer	0.00264	0.00349	CcSEcCtD
Ipratropium bromide—Diarrhoea—Vandetanib—thyroid cancer	0.00263	0.00347	CcSEcCtD
Ipratropium bromide—Ulcer—Doxorubicin—thyroid cancer	0.00262	0.00346	CcSEcCtD
Ipratropium bromide—Salivary hypersecretion—Epirubicin—thyroid cancer	0.0026	0.00344	CcSEcCtD
Ipratropium bromide—Influenza like illness—Epirubicin—thyroid cancer	0.0026	0.00344	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Sorafenib—thyroid cancer	0.00259	0.00342	CcSEcCtD
Ipratropium bromide—Infection—Sorafenib—thyroid cancer	0.00257	0.0034	CcSEcCtD
Ipratropium bromide—Inflammation—Doxorubicin—thyroid cancer	0.00256	0.00338	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Sorafenib—thyroid cancer	0.00254	0.00335	CcSEcCtD
Ipratropium bromide—Dizziness—Vandetanib—thyroid cancer	0.00254	0.00335	CcSEcCtD
Ipratropium bromide—Skin disorder—Sorafenib—thyroid cancer	0.00252	0.00332	CcSEcCtD
Ipratropium bromide—Vomiting—Vandetanib—thyroid cancer	0.00244	0.00322	CcSEcCtD
Ipratropium bromide—Rash—Vandetanib—thyroid cancer	0.00242	0.00319	CcSEcCtD
Ipratropium bromide—Dermatitis—Vandetanib—thyroid cancer	0.00242	0.00319	CcSEcCtD
Ipratropium bromide—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.00241	0.00318	CcSEcCtD
Ipratropium bromide—Influenza like illness—Doxorubicin—thyroid cancer	0.00241	0.00318	CcSEcCtD
Ipratropium bromide—Headache—Vandetanib—thyroid cancer	0.0024	0.00317	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00236	0.00311	CcSEcCtD
Ipratropium bromide—Abnormal vision—Epirubicin—thyroid cancer	0.00234	0.00309	CcSEcCtD
Ipratropium bromide—Dyspnoea—Sorafenib—thyroid cancer	0.00231	0.00305	CcSEcCtD
Ipratropium bromide—Nausea—Vandetanib—thyroid cancer	0.00228	0.00301	CcSEcCtD
Ipratropium bromide—Dyspepsia—Sorafenib—thyroid cancer	0.00228	0.00301	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00224	0.00295	CcSEcCtD
Ipratropium bromide—Fatigue—Sorafenib—thyroid cancer	0.00223	0.00295	CcSEcCtD
Ipratropium bromide—Pain—Sorafenib—thyroid cancer	0.00221	0.00292	CcSEcCtD
Ipratropium bromide—Constipation—Sorafenib—thyroid cancer	0.00221	0.00292	CcSEcCtD
Ipratropium bromide—Abnormal vision—Doxorubicin—thyroid cancer	0.00216	0.00286	CcSEcCtD
Ipratropium bromide—Eye pain—Epirubicin—thyroid cancer	0.00216	0.00285	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00212	0.00279	CcSEcCtD
Ipratropium bromide—SLC22A5—lymph node—thyroid cancer	0.00207	0.0168	CbGeAlD
Ipratropium bromide—Urticaria—Sorafenib—thyroid cancer	0.00206	0.00272	CcSEcCtD
Ipratropium bromide—Abdominal pain—Sorafenib—thyroid cancer	0.00205	0.0027	CcSEcCtD
Ipratropium bromide—Eye pain—Doxorubicin—thyroid cancer	0.002	0.00263	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Sorafenib—thyroid cancer	0.00191	0.00252	CcSEcCtD
Ipratropium bromide—CYP2D6—head—thyroid cancer	0.00191	0.0154	CbGeAlD
Ipratropium bromide—Asthenia—Sorafenib—thyroid cancer	0.00186	0.00245	CcSEcCtD
Ipratropium bromide—Pruritus—Sorafenib—thyroid cancer	0.00183	0.00242	CcSEcCtD
Ipratropium bromide—Diarrhoea—Sorafenib—thyroid cancer	0.00177	0.00234	CcSEcCtD
Ipratropium bromide—Dizziness—Sorafenib—thyroid cancer	0.00171	0.00226	CcSEcCtD
Ipratropium bromide—Asthma—Epirubicin—thyroid cancer	0.00168	0.00222	CcSEcCtD
Ipratropium bromide—Dysphagia—Epirubicin—thyroid cancer	0.00168	0.00222	CcSEcCtD
Ipratropium bromide—Influenza—Epirubicin—thyroid cancer	0.00168	0.00222	CcSEcCtD
Ipratropium bromide—Vomiting—Sorafenib—thyroid cancer	0.00165	0.00217	CcSEcCtD
Ipratropium bromide—Rash—Sorafenib—thyroid cancer	0.00163	0.00216	CcSEcCtD
Ipratropium bromide—Dermatitis—Sorafenib—thyroid cancer	0.00163	0.00215	CcSEcCtD
Ipratropium bromide—Headache—Sorafenib—thyroid cancer	0.00162	0.00214	CcSEcCtD
Ipratropium bromide—Bronchitis—Epirubicin—thyroid cancer	0.00162	0.00214	CcSEcCtD
Ipratropium bromide—Dysuria—Epirubicin—thyroid cancer	0.00157	0.00208	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00156	0.00206	CcSEcCtD
Ipratropium bromide—Dysphagia—Doxorubicin—thyroid cancer	0.00156	0.00206	CcSEcCtD
Ipratropium bromide—Asthma—Doxorubicin—thyroid cancer	0.00156	0.00206	CcSEcCtD
Ipratropium bromide—Influenza—Doxorubicin—thyroid cancer	0.00156	0.00206	CcSEcCtD
Ipratropium bromide—Pollakiuria—Epirubicin—thyroid cancer	0.00155	0.00205	CcSEcCtD
Ipratropium bromide—Nausea—Sorafenib—thyroid cancer	0.00154	0.00203	CcSEcCtD
Ipratropium bromide—Bronchitis—Doxorubicin—thyroid cancer	0.0015	0.00198	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00147	0.00194	CcSEcCtD
Ipratropium bromide—Stomatitis—Epirubicin—thyroid cancer	0.00146	0.00193	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Epirubicin—thyroid cancer	0.00146	0.00193	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Epirubicin—thyroid cancer	0.00146	0.00193	CcSEcCtD
Ipratropium bromide—Dysuria—Doxorubicin—thyroid cancer	0.00146	0.00192	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00145	0.00191	CcSEcCtD
Ipratropium bromide—Sweating—Epirubicin—thyroid cancer	0.00144	0.0019	CcSEcCtD
Ipratropium bromide—Pollakiuria—Doxorubicin—thyroid cancer	0.00144	0.0019	CcSEcCtD
Ipratropium bromide—Epistaxis—Epirubicin—thyroid cancer	0.00142	0.00187	CcSEcCtD
Ipratropium bromide—Sinusitis—Epirubicin—thyroid cancer	0.00141	0.00186	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00136	0.0018	CcSEcCtD
Ipratropium bromide—Haemoglobin—Epirubicin—thyroid cancer	0.00135	0.00179	CcSEcCtD
Ipratropium bromide—Stomatitis—Doxorubicin—thyroid cancer	0.00135	0.00179	CcSEcCtD
Ipratropium bromide—Rhinitis—Epirubicin—thyroid cancer	0.00135	0.00178	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Doxorubicin—thyroid cancer	0.00135	0.00178	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Doxorubicin—thyroid cancer	0.00135	0.00178	CcSEcCtD
Ipratropium bromide—Haemorrhage—Epirubicin—thyroid cancer	0.00135	0.00178	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Epirubicin—thyroid cancer	0.00134	0.00177	CcSEcCtD
Ipratropium bromide—Pharyngitis—Epirubicin—thyroid cancer	0.00134	0.00176	CcSEcCtD
Ipratropium bromide—Sweating—Doxorubicin—thyroid cancer	0.00133	0.00176	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Epirubicin—thyroid cancer	0.00133	0.00176	CcSEcCtD
Ipratropium bromide—Urethral disorder—Epirubicin—thyroid cancer	0.00132	0.00174	CcSEcCtD
Ipratropium bromide—Epistaxis—Doxorubicin—thyroid cancer	0.00131	0.00173	CcSEcCtD
Ipratropium bromide—Sinusitis—Doxorubicin—thyroid cancer	0.0013	0.00172	CcSEcCtD
Ipratropium bromide—Visual impairment—Epirubicin—thyroid cancer	0.0013	0.00171	CcSEcCtD
Ipratropium bromide—Eye disorder—Epirubicin—thyroid cancer	0.00126	0.00166	CcSEcCtD
Ipratropium bromide—Tinnitus—Epirubicin—thyroid cancer	0.00126	0.00166	CcSEcCtD
Ipratropium bromide—Haemoglobin—Doxorubicin—thyroid cancer	0.00125	0.00165	CcSEcCtD
Ipratropium bromide—Flushing—Epirubicin—thyroid cancer	0.00125	0.00165	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Epirubicin—thyroid cancer	0.00125	0.00165	CcSEcCtD
Ipratropium bromide—Rhinitis—Doxorubicin—thyroid cancer	0.00125	0.00165	CcSEcCtD
Ipratropium bromide—Haemorrhage—Doxorubicin—thyroid cancer	0.00125	0.00165	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00124	0.00164	CcSEcCtD
Ipratropium bromide—Pharyngitis—Doxorubicin—thyroid cancer	0.00124	0.00163	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Doxorubicin—thyroid cancer	0.00123	0.00162	CcSEcCtD
Ipratropium bromide—Urethral disorder—Doxorubicin—thyroid cancer	0.00122	0.00161	CcSEcCtD
Ipratropium bromide—Immune system disorder—Epirubicin—thyroid cancer	0.00122	0.00161	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Epirubicin—thyroid cancer	0.00121	0.0016	CcSEcCtD
Ipratropium bromide—Visual impairment—Doxorubicin—thyroid cancer	0.0012	0.00159	CcSEcCtD
Ipratropium bromide—Eye disorder—Doxorubicin—thyroid cancer	0.00116	0.00154	CcSEcCtD
Ipratropium bromide—Tinnitus—Doxorubicin—thyroid cancer	0.00116	0.00153	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Doxorubicin—thyroid cancer	0.00116	0.00153	CcSEcCtD
Ipratropium bromide—Flushing—Doxorubicin—thyroid cancer	0.00116	0.00153	CcSEcCtD
Ipratropium bromide—Flatulence—Epirubicin—thyroid cancer	0.00116	0.00153	CcSEcCtD
Ipratropium bromide—Tension—Epirubicin—thyroid cancer	0.00115	0.00152	CcSEcCtD
Ipratropium bromide—Dysgeusia—Epirubicin—thyroid cancer	0.00115	0.00152	CcSEcCtD
Ipratropium bromide—Nervousness—Epirubicin—thyroid cancer	0.00114	0.0015	CcSEcCtD
Ipratropium bromide—Back pain—Epirubicin—thyroid cancer	0.00113	0.0015	CcSEcCtD
Ipratropium bromide—Immune system disorder—Doxorubicin—thyroid cancer	0.00113	0.00149	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00112	0.00148	CcSEcCtD
Ipratropium bromide—Vision blurred—Epirubicin—thyroid cancer	0.00111	0.00146	CcSEcCtD
Ipratropium bromide—Flatulence—Doxorubicin—thyroid cancer	0.00107	0.00141	CcSEcCtD
Ipratropium bromide—Tension—Doxorubicin—thyroid cancer	0.00106	0.00141	CcSEcCtD
Ipratropium bromide—Dysgeusia—Doxorubicin—thyroid cancer	0.00106	0.0014	CcSEcCtD
Ipratropium bromide—Nervousness—Doxorubicin—thyroid cancer	0.00105	0.00139	CcSEcCtD
Ipratropium bromide—Back pain—Doxorubicin—thyroid cancer	0.00105	0.00139	CcSEcCtD
Ipratropium bromide—Palpitations—Epirubicin—thyroid cancer	0.00104	0.00137	CcSEcCtD
Ipratropium bromide—Cough—Epirubicin—thyroid cancer	0.00102	0.00135	CcSEcCtD
Ipratropium bromide—Vision blurred—Doxorubicin—thyroid cancer	0.00102	0.00135	CcSEcCtD
Ipratropium bromide—Hypertension—Epirubicin—thyroid cancer	0.00101	0.00134	CcSEcCtD
Ipratropium bromide—Chest pain—Epirubicin—thyroid cancer	0.000998	0.00132	CcSEcCtD
Ipratropium bromide—Myalgia—Epirubicin—thyroid cancer	0.000998	0.00132	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000991	0.00131	CcSEcCtD
Ipratropium bromide—Dry mouth—Epirubicin—thyroid cancer	0.000976	0.00129	CcSEcCtD
Ipratropium bromide—Palpitations—Doxorubicin—thyroid cancer	0.000959	0.00127	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Epirubicin—thyroid cancer	0.000957	0.00126	CcSEcCtD
Ipratropium bromide—Oedema—Epirubicin—thyroid cancer	0.000957	0.00126	CcSEcCtD
Ipratropium bromide—Infection—Epirubicin—thyroid cancer	0.000951	0.00125	CcSEcCtD
Ipratropium bromide—Cough—Doxorubicin—thyroid cancer	0.000947	0.00125	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Epirubicin—thyroid cancer	0.000938	0.00124	CcSEcCtD
Ipratropium bromide—Hypertension—Doxorubicin—thyroid cancer	0.000937	0.00124	CcSEcCtD
Ipratropium bromide—Tachycardia—Epirubicin—thyroid cancer	0.000934	0.00123	CcSEcCtD
Ipratropium bromide—Skin disorder—Epirubicin—thyroid cancer	0.000929	0.00123	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Epirubicin—thyroid cancer	0.000925	0.00122	CcSEcCtD
Ipratropium bromide—Chest pain—Doxorubicin—thyroid cancer	0.000924	0.00122	CcSEcCtD
Ipratropium bromide—Myalgia—Doxorubicin—thyroid cancer	0.000924	0.00122	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000917	0.00121	CcSEcCtD
Ipratropium bromide—Dry mouth—Doxorubicin—thyroid cancer	0.000903	0.00119	CcSEcCtD
Ipratropium bromide—Hypotension—Epirubicin—thyroid cancer	0.000894	0.00118	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000885	0.00117	CcSEcCtD
Ipratropium bromide—Oedema—Doxorubicin—thyroid cancer	0.000885	0.00117	CcSEcCtD
Ipratropium bromide—Infection—Doxorubicin—thyroid cancer	0.00088	0.00116	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000872	0.00115	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Doxorubicin—thyroid cancer	0.000868	0.00115	CcSEcCtD
Ipratropium bromide—Insomnia—Epirubicin—thyroid cancer	0.000866	0.00114	CcSEcCtD
Ipratropium bromide—Tachycardia—Doxorubicin—thyroid cancer	0.000864	0.00114	CcSEcCtD
Ipratropium bromide—Skin disorder—Doxorubicin—thyroid cancer	0.00086	0.00114	CcSEcCtD
Ipratropium bromide—Paraesthesia—Epirubicin—thyroid cancer	0.000859	0.00113	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000856	0.00113	CcSEcCtD
Ipratropium bromide—Dyspnoea—Epirubicin—thyroid cancer	0.000853	0.00113	CcSEcCtD
Ipratropium bromide—Somnolence—Epirubicin—thyroid cancer	0.000851	0.00112	CcSEcCtD
Ipratropium bromide—Dyspepsia—Epirubicin—thyroid cancer	0.000842	0.00111	CcSEcCtD
Ipratropium bromide—Hypotension—Doxorubicin—thyroid cancer	0.000827	0.00109	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000826	0.00109	CcSEcCtD
Ipratropium bromide—Fatigue—Epirubicin—thyroid cancer	0.000825	0.00109	CcSEcCtD
Ipratropium bromide—Constipation—Epirubicin—thyroid cancer	0.000818	0.00108	CcSEcCtD
Ipratropium bromide—Pain—Epirubicin—thyroid cancer	0.000818	0.00108	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000807	0.00106	CcSEcCtD
Ipratropium bromide—Insomnia—Doxorubicin—thyroid cancer	0.000801	0.00106	CcSEcCtD
Ipratropium bromide—Paraesthesia—Doxorubicin—thyroid cancer	0.000795	0.00105	CcSEcCtD
Ipratropium bromide—Dyspnoea—Doxorubicin—thyroid cancer	0.000789	0.00104	CcSEcCtD
Ipratropium bromide—Somnolence—Doxorubicin—thyroid cancer	0.000787	0.00104	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000783	0.00103	CcSEcCtD
Ipratropium bromide—Dyspepsia—Doxorubicin—thyroid cancer	0.000779	0.00103	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000764	0.00101	CcSEcCtD
Ipratropium bromide—Fatigue—Doxorubicin—thyroid cancer	0.000763	0.00101	CcSEcCtD
Ipratropium bromide—Urticaria—Epirubicin—thyroid cancer	0.00076	0.001	CcSEcCtD
Ipratropium bromide—Pain—Doxorubicin—thyroid cancer	0.000757	0.000999	CcSEcCtD
Ipratropium bromide—Constipation—Doxorubicin—thyroid cancer	0.000757	0.000999	CcSEcCtD
Ipratropium bromide—Abdominal pain—Epirubicin—thyroid cancer	0.000756	0.000999	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000724	0.000956	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Epirubicin—thyroid cancer	0.000705	0.000931	CcSEcCtD
Ipratropium bromide—Urticaria—Doxorubicin—thyroid cancer	0.000703	0.000928	CcSEcCtD
Ipratropium bromide—Abdominal pain—Doxorubicin—thyroid cancer	0.0007	0.000924	CcSEcCtD
Ipratropium bromide—Asthenia—Epirubicin—thyroid cancer	0.000687	0.000906	CcSEcCtD
Ipratropium bromide—Pruritus—Epirubicin—thyroid cancer	0.000677	0.000894	CcSEcCtD
Ipratropium bromide—Diarrhoea—Epirubicin—thyroid cancer	0.000655	0.000864	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Doxorubicin—thyroid cancer	0.000652	0.000861	CcSEcCtD
Ipratropium bromide—Asthenia—Doxorubicin—thyroid cancer	0.000635	0.000839	CcSEcCtD
Ipratropium bromide—Dizziness—Epirubicin—thyroid cancer	0.000633	0.000835	CcSEcCtD
Ipratropium bromide—Pruritus—Doxorubicin—thyroid cancer	0.000626	0.000827	CcSEcCtD
Ipratropium bromide—Vomiting—Epirubicin—thyroid cancer	0.000608	0.000803	CcSEcCtD
Ipratropium bromide—Diarrhoea—Doxorubicin—thyroid cancer	0.000606	0.0008	CcSEcCtD
Ipratropium bromide—Rash—Epirubicin—thyroid cancer	0.000603	0.000796	CcSEcCtD
Ipratropium bromide—Dermatitis—Epirubicin—thyroid cancer	0.000603	0.000796	CcSEcCtD
Ipratropium bromide—Headache—Epirubicin—thyroid cancer	0.000599	0.000791	CcSEcCtD
Ipratropium bromide—Dizziness—Doxorubicin—thyroid cancer	0.000586	0.000773	CcSEcCtD
Ipratropium bromide—Nausea—Epirubicin—thyroid cancer	0.000568	0.00075	CcSEcCtD
Ipratropium bromide—Vomiting—Doxorubicin—thyroid cancer	0.000563	0.000743	CcSEcCtD
Ipratropium bromide—Rash—Doxorubicin—thyroid cancer	0.000558	0.000737	CcSEcCtD
Ipratropium bromide—Dermatitis—Doxorubicin—thyroid cancer	0.000558	0.000736	CcSEcCtD
Ipratropium bromide—Headache—Doxorubicin—thyroid cancer	0.000555	0.000732	CcSEcCtD
Ipratropium bromide—Nausea—Doxorubicin—thyroid cancer	0.000526	0.000694	CcSEcCtD
